Gefitinib in the treatment of elderly patients with advanced non-small cell lung cancer (NSCLC)

Lung Cancer. 2007 Jan;55(1):125-7. doi: 10.1016/j.lungcan.2006.09.017. Epub 2006 Oct 24.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Age Factors
  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Carcinoma, Non-Small-Cell Lung / pathology
  • Female
  • Gefitinib
  • Humans
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / pathology
  • Male
  • Neoplasm Staging
  • Quinazolines / therapeutic use*

Substances

  • Antineoplastic Agents
  • Quinazolines
  • Gefitinib